Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Food-effect study of single-dose TAK-536TCH in healthy Japanese males
jRCT2080222725Phase 1
- Sponsor
- Takeda
- Start
- Jan 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of azilsartan + amlodipine + hydrochlorothiazide in hypertension (HTN) (2 arms), sponsored by Takeda. Primary endpoint: Food effect on pharmacokinetics of TAK-536TCH.
02
Drugs
azilsartan + amlodipine + hydrochlorothiazide
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on jRCT2080222725.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080222725.